Bibliography

Filters: First Letter Of Keyword is A  [Clear All Filters]
[A] B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
Aged
Böckerman P, Johansson E, Saarni SI. Do established health-related quality-of-life measures adequately capture the impact of chronic conditions on subjective well-being? Health Policy. 2011;100(1):91-5. Abstract
Lehoux P. Patients' perspectives on high-tech home care: a qualitative inquiry into the user-friendliness of four technologies. BMC Health Serv Res. 2004;4(1):28. Abstract
Kastner M, Straus SE, McKibbon AK, Goldsmith CH. The capture-mark-recapture technique can be used as a stopping rule when searching in systematic reviews. J Clin Epidemiol. 2009;62(2):149-57. Abstract
Molster C, Maxwell S, Youngs L, Kyne G, Hope F, Dawkins H, et al. Blueprint for a deliberative public forum on biobanking policy: were theoretical principles achievable in practice? Health Expect. 2013;16(2):211-24. Abstract
Engel L, Bryan S, Evers SM, Dirksen CD, Noonan VK, Whitehurst DG. Exploring psychometric properties of the SF-6D, a preference-based health-related quality of life measure, in the context of spinal cord injury. Qual Life Res. 2014;23(8):2383-93. Abstract
Jørgensen T, Hvenegaard A, Kristensen FB. Health technology assessment in Denmark. Int J Technol Assess Health Care. 2000;16(2):347-81. Abstract
Faisst K, Schilling J, Koch P. Health technology assessment of three screening methods in Switzerland. Int J Technol Assess Health Care. 2001;17(3):389-99. Abstract
Lehoux P, Poland B, Daudelin G. Focus group research and "the patient's view". Soc Sci Med. 2006;63(8):2091-104. Abstract
Lehoux P, Blume S. Technology assessment and the sociopolitics of health technologies. J Health Polit Policy Law. 2000;25(6):1083-120. Abstract
Bombard Y, Abelson J, Simeonov D, Gauvin F-. Eliciting ethical and social values in health technology assessment: A participatory approach. Soc Sci Med. 2011;73(1):135-44. Abstract
Izquierdo F, Gracia J, Guerra M, Blasco JA, Andradas E. Health technology assessment-based development of a Spanish breast cancer patient decision aid. Int J Technol Assess Health Care. 2011;27(4):363-8. Abstract
Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, Kris MG, et al. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol. 2013;31(20):2580-5. Abstract
Granados A, Sampietro-Colom L, Asua J, Conde J, Vazquez-Albertino R. Health technology assessment in Spain. Int J Technol Assess Health Care. 2000;16(2):532-59. Abstract
Age Factors
Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, Kris MG, et al. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol. 2013;31(20):2580-5. Abstract
Sullivan SM, Tsiplova K, Ungar WJ. A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease? Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):599-607. Abstract
Shenderovich Y, Eisner M, Mikton C, Gardner F, Liu J, Murray J. Methods for conducting systematic reviews of risk factors in low- and middle-income countries. BMC Med Res Methodol. 2016;16:32. Abstract
Advisory Committees
Takla A, Wichmann O, Carrillo-Santisteve P, Cotter S, Levy-Bruhl D, Paradowska-Stankiewicz I, et al. Characteristics and practices of National Immunisation Technical Advisory Groups in Europe and potential for collaboration, April 2014. Euro Surveill. 2015;20(9). Abstract
Gansen FM. Health economic evaluations based on routine data in Germany: a systematic review. BMC Health Serv Res. 2018;18(1):268. Abstract
Abelson J, Bombard Y, Gauvin F-, Simeonov D, Boesveld S. Assessing the impacts of citizen deliberations on the health technology process. Int J Technol Assess Health Care. 2013;29(3):282-9. Abstract
O'Malley SP. Issues facing the Australian Health Technology Assessment Review of medical technology funding. Med J Aust. 2010;193(1):30-3. Abstract
Brazier J, Ara R, Azzabi I, Busschbach J, Chevrou-Séverac H, Crawford B, et al. Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report. Value Health. 2019;22(3):267-75. Abstract
Adverse Drug Reaction Reporting Systems
Pietanza CM, Basch EM, Lash A, Schwartz LH, Ginsberg MS, Zhao B, et al. Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial. J Clin Oncol. 2013;31(16):2004-9. Abstract
Derry S, Loke YK, Aronson JK. Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med Res Methodol. 2001;1:7. Abstract
Banerjee AK, Okun S, Edwards RI, Wicks P, Smith MY, Mayall SJ, et al. Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance. Drug Saf. 2013;36(12):1129-49. Abstract
Golder S, Loke YK. Failure or success of electronic search strategies to identify adverse effects data. J Med Libr Assoc. 2012;100(2):130-4.